Tag: #AsthmaOverlap
-
Assessing High Dose ICS in COPD Patients with Elevated FeNO Are ShortTerm Gains Real
Introduction: Emerging research challenges the assumption that inhaled corticosteroids (ICS) uniformly benefit all chronic obstructive pulmonary disease (COPD) patients. A recent single-centre study explored whether COPD patients with fractional exhaled nitric oxide (FeNO) concentrations above 35 parts per billion (ppb) show measurable pulmonary improvements following a 28-day high-dose ICS treatment. Despite targeted inclusion criteria, the…
Heighten Science Publications Inc. 